TITLE

Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use

AUTHOR(S)
Mareschi, Katia; Rustichelli, Deborah; Calabrese, Roberto; Gunetti, Monica; Sanavio, Fiorella; Castiglia, Sara; Risso, Alessandra; Ferrero, Ivana; Tarella, Corrado; Fagioli, Franca
PUB. DATE
January 2012
SOURCE
Stem Cells International;2012, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mesenchymal stem cells (MSCs) are a promising source for cell therapy due to their pluripotency and immunomodulant proprieties. As the identification of "optimal" conditions is important to identify a standard procedure for clinical use. Percoll, Ficoll and whole bone marrow directly plated were tested from the same sample as separation methods. The cells were seeded at the following densities: 100 000, 10 000, 1000, 100, 10 cells/cm2. After reaching confluence, the cells were detached, pooled and re-plated at 1000, 500, 100, and 10 cells/cm2. Statistical analyses were performed. Cumulative Population Doublings (PD) did not show significant differences for the separation methods and seeding densities but only for the plating density. Some small quantity samples plated in T25 flasks at plating densities of 10 and 100 cells/cm2 did not produce any expansion. However, directly plated whole bone marrow resulted in a more advantageous method in terms of CFU-F number, cellular growth and minimal manipulation. No differences were observed in terms of gross morphology, differentiation potential or immunophenotype. These data suggest that plating whole bone marrow at a low cellular density may represent a good procedure for MSC expansion for clinical use.
ACCESSION #
87093919

 

Related Articles

  • Mitochondrial Respiration Regulates Adipogenic Differentiation of Human Mesenchymal Stem Cells. Zhang, Yanmin; Marsboom, Glenn; Toth, Peter T.; Rehman, Jalees // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Human mesenchymal stem cells (MSCs) are adult multipotent stem cells which can be isolated from bone marrow, adipose tissue as well as other tissues and have the capacity to differentiate into a variety of mesenchymal cell types such as adipocytes, osteoblasts and chondrocytes. Differentiation...

  • CD105 (Endoglin)-Negative Murine Mesenchymal Stromal Cells Define a New Multipotent Subpopulation with Distinct Differentiation and Immunomodulatory Capacities. Anderson, Per; Carrillo-Gálvez, Ana Belén; García-Pérez, Angélica; Cobo, Marién; Martín, Francisco // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo- and xenogeneic settings. However, MSC preparations are heterogeneous which...

  • Neurotrophins Regulate Bone Marrow Stromal Cell IL-6 Expression through the MAPK Pathway. Rezaee, Fariba; Rellick, Stephanie L.; Piedimonte, Giovanni; Akers, Stephen M.; O'Leary, Heather A.; Martin, Karen; Craig, Michael D.; Gibson, Laura F. // PLoS ONE;2010, Vol. 5 Issue 3, p1 

    Background: The host's response to infection is characterized by altered levels of neurotrophins and an influx of inflammatory cells to sites of injured tissue. Progenitor cells that give rise to the differentiated cellular mediators of inflammation are derived from bone marrow progenitor cells...

  • Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice Neirinckx, Virginie; Marquet, Alice; Coste, Cécile; Rogister, Bernard; Wislet-Gendebien, Sabine // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Adult bone marrow stroma contains multipotent stem cells (BMSC) that are a mixed population of mesenchymal and neural-crest derived stem cells. Both cells are endowed with in vitro multi-lineage differentiation abilities, then constituting an attractive and easy-available source of material for...

  • Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Shenaq, Deana S.; Rastegar, Farbod; Petkovic, Djuro; Bing-Qiang Zhang; Bai-ChengHe; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Wagner, Eric R.; Enyi Huang; Yanhong Gao; Jian-Li Gao; Kim, Stephanie H.; Ke Yang; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo // Stem Cells International;2010, p1 

    Mesenchymal progenitor cells (MPCs) are nonhematopoietic multipotent cells capable of differentiating into mesenchymal and nonmesenchymal lineages. While they can be isolated from various tissues, MPCs isolated from the bone marrow are best characterized. These cells represent a subset of bone...

  • In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells.  // BMC Developmental Biology;2012, Vol. 12 Issue 1, p7 

    The article focuses on in vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells. Study isolates skin stromal cells (SSCs) from human neonatal foreskin (hNFSSCs) and adult dermal skin (hADSSCs) and were compared with bone marrow (hMSC-TERT) and...

  • Risk of genetic transformation of multipotent mesenchymal stromal cells in vitro. Nikitina, V.; Chausheva, A. // Russian Journal of Genetics;Jan2014, Vol. 50 Issue 1, p91 

    Proof of the efficacy of cell therapy by numerous studies and clinical trials inevitably has raised the question of improving the regulatory framework that governs its use. Particular attention should be paid to the genetic safety of cell preparations. The immune, genetic, and pharmacological...

  • Mesenchymal Stromal Cell Phenotype is not Influenced by Confluence during Culture Expansion. Haack-Sørensen, Mandana; Hansen, Susanne; Hansen, Louise; Gaster, Michael; Hyttel, Poul; Ekblond, Annette; Kastrup, Jens // Stem Cell Reviews & Reports;Feb2013, Vol. 9 Issue 1, p44 

    Background: Accumulating preclinical and clinical evidence indicates that human mesenchymal stromal cells (MSCs) are good candidates for cell therapy. For clinical applications of MSCs extensive in vitro expansion is required to obtain an adequate number of cells. It is evident that the pursuit...

  • Long Term Expansion of Bone Marrow-Derived hMSCs on Novel Synthetic Microcarriers in Xeno-Free, Defined Conditions. Hervy, Martial; Weber, Jennifer L.; Pecheul, Marylene; Dolley-Sonneville, Paula; Henry, David; Zhou, Yue; Melkoumian, Zara // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Human mesenchymal stem cells (hMSCs) present an attractive target for cell therapy given their wide availability, immunomodulatory properties, and multipotent nature for differentiation into chondrocytes, osteocytes, and adipocytes. With the progression of hMSC clinical studies, there is an...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics